Hiraoka, K., Inagaki, A., Kato, Y., Huang, T. T., Mitchell, L. A., Kamijima, S., . . . Kasahara, N. (2017). Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity. Neuro Oncol.
Stile di citazione ChicagoHiraoka, Kei, et al. "Retroviral Replicating Vector–mediated Gene Therapy Achieves Long-term Control of Tumor Recurrence and Leads to Durable Anticancer Immunity." Neuro Oncol 2017.
Citazione MLAHiraoka, Kei, et al. "Retroviral Replicating Vector–mediated Gene Therapy Achieves Long-term Control of Tumor Recurrence and Leads to Durable Anticancer Immunity." Neuro Oncol 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.